Mike Coyle Steps Down As iRhythm CEO; CFO Douglas Devine Will Be Interim CEO
Douglas Devine will take over as interim CEO as iRhythm tries to resolve reimbursement challenges and roll out the next generation of its Zio remote cardiac monitor with an updated artificial intelligence system.
You may also be interested in...
Exec Chat: New iRhythm CEO Foresees Enormous Opportunity In AI For Arrhythmia Detection
Quentin Blackford, who recently became iRhythm’s CEO after serving as Dexcom’s chief operating officer, talked to Medtech Insight about the challenges and opportunities in the emerging remote cardiac monitoring market.
Dexcom COO Quentin Blackford Takes CEO Job At iRhythm
The move is supported by iRhythm investors and disappointed Dexcom’s shareholders.
iRhythm Is ‘Encouraged’ By Recent Reimbursement Discussions With Novitas
The company provided another update on its ongoing efforts to secure adequate Medicare reimbursement for long-term continuous cardiac monitoring.